about
Advanced Glycation End Products: Link between Diet and Ovulatory Dysfunction in PCOS?Advanced glycation end products and diabetic complicationsVitamin D and assisted reproduction: should vitamin D be routinely screened and repleted prior to ART? A systematic reviewPossible links between intestinal permeability and food processing: A potential therapeutic niche for glutamineRosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products.Increased expression and local accumulation of the prion protein, Alzheimer Aβ peptides, superoxide dismutase 1, and nitric oxide synthases 1 & 2 in muscle in a rabbit model of diabetes.Macrophage Migration Inhibitory Factor is subjected to glucose modification and oxidation in Alzheimer's Disease.Dietary consumption of advanced glycation end products and pancreatic cancer in the prospective NIH-AARP Diet and Health Study.TCF7L2 polymorphism and cognitive test performance in cardiovascular disease.Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study.Soluble HMGB1 is a novel adipokine stimulating IL-6 secretion through RAGE receptor in SW872 preadipocyte cell line: contribution to chronic inflammation in fat tissueThe role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseasesRelationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal WomenAnalysis of protein glycation using fluorescent phenylboronate gel electrophoresis.Beta-thalassemia major and female fertility: the role of iron and iron-induced oxidative stress.Glucagon-like peptide-1 secreting cell function as well as production of inflammatory reactive oxygen species is differently regulated by glycated serum and high levels of glucose.An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients.Modern approach to metabolic rehabilitation of cancer patients: biguanides (phenformin and metformin) and beyond.Review article: fructose in non-alcoholic fatty liver disease.Insulin resistance: an emerging link in Alzheimer's disease.Aspalathin improves hyperglycemia and glucose intolerance in obese diabetic ob/ob mice.Inhibitory activities of acteoside, isoacteoside, and its structural constituents against protein glycation in vitro.Cardiovascular dementia - a different perspective.Processed Meat, but Not Unprocessed Red Meat, Is Inversely Associated with Leukocyte Telomere Length in the Strong Heart Family Study.Effects of berberine on amelioration of hyperglycemia and oxidative stress in high glucose and high fat diet-induced diabetic hamsters in vivo.Immunological detection of fructose-derived advanced glycation end-products.Serum advanced glycation end products (AGEs) are associated with insulin resistance.Soluble receptor and gene polymorphism for AGE: relationship with obesity and cardiovascular risks.Insulin Resistance and Alzheimer's Disease: Bioenergetic Linkages.An overview of in vitro and in vivo glycation of albumin: a potential disease marker in diabetes mellitus.Obesity induced alterations in redox homeostasis and oxidative stress are present from an early age.Asn-Trp dipeptides improve the oxidative stress and learning dysfunctions in D-galactose-induced BALB/c mice.Advanced glycation end-products accumulation compromises embryonic development and achievement of pregnancy by assisted reproductive technology.Intramuscular injection of soluble receptor for advanced glycation endproducts expression vector prevents the development of streptozotocin-induced diabetes mellitus in rats on high fat diet.DNA-aptamers raised against AGEs as a blocker of various aging-related disorders.Enhanced external counterpulsation (EECP) decreases advanced glycation end products and proinflammatory cytokines in patients with non-insulin-dependent type II diabetes mellitus for up to 6 months following treatment.Advanced glycation end products downregulate glucokinase in mice.A long-standing hyperglycaemic condition impairs skin barrier by accelerating skin ageing process.Investigating the Glycating Effects of Glucose, Glyoxal and Methylglyoxal on Human Sperm.Glycated albumin. A glycemic control index to be reevaluated
P2860
Q26774333-37209A9F-C1B4-4B9B-A031-914E44DA41DFQ27687501-321D3DCD-1694-476F-B46B-DA81911EE01DQ28080454-43840FE2-056E-4CB4-A910-6FE16998884CQ28287402-768D1A6E-8468-4B3C-B8D6-EBBFD9AADBE6Q33595290-614C929A-A2E4-4A5E-A0F2-2062C800F761Q33684979-A874A83E-44A1-4FEF-9FB1-A147B63E1721Q34551906-A6A2809B-EBEE-4568-8C72-778E92A1DF4FQ34706565-193DC822-7309-4DD3-931E-1FBA8A2C588DQ34901664-546E51C9-018F-4018-A0B2-E79CA334D339Q34987953-3ACDA636-E03D-4605-A7F8-FCA8A21B2D15Q35000952-F3689546-58B4-4311-9BB9-B31CC03755A5Q35867073-103DE7C0-21DC-454F-927E-8068F1C66F80Q36047141-8D1F765C-C897-4ABA-8046-E1C9A377AA28Q36718919-0A15A227-C736-4912-A6E1-15328DC50B31Q37422608-D7731D82-5170-4C27-994C-6DF92BB1F3A6Q37598515-05E0BB53-EDBB-4107-9EC2-429FD1A3466FQ37609701-5FF290A6-BE96-443F-8309-1A57C64B725EQ37783621-51BF80CD-0AB2-4DDB-A36A-0007EF8C428AQ37999116-AA1EC930-BCEA-4924-84B6-290D51911D0FQ38106633-0308A8AA-2469-4BB5-880D-E8AE09031C45Q38319272-D16214C6-648B-444F-B03D-A08BBF173CE3Q38782701-9B352C0E-A4CC-4490-8F41-2435F45213D9Q40361355-43575476-0D07-4C45-A75F-DC55D194F7B3Q40608459-7EC69F81-00D7-479E-9822-508EE68543FFQ41841136-C7897ED4-3AC7-40C4-A2C8-3A660C7A57C9Q43138020-1776642D-FE31-41B8-9234-59AFBB8D6DDDQ46126412-0FAF4C39-8A3D-4633-86B1-4676892F34DBQ46151254-960B585F-D42A-479E-BBE0-C30614AC0ED1Q46799102-F243390A-D5D1-4E7E-9F0D-FDB388252E96Q47947254-E3EBEB5C-A1D2-4257-8D4B-2F24CC969DD9Q48165451-1D9BD145-F039-4AB5-896C-9BD02C508004Q48641183-E858B675-C7CB-49F2-8039-D8DA16FE05E7Q48683430-B5112267-7684-45C0-B97F-D0F5FA1AFC53Q51368824-982D8FAD-E359-49D4-8F9B-86EA4602B848Q51685125-01BD21FC-E911-4B6D-BEF6-1CBD56756031Q51712877-B7E3BCB9-3736-444E-B3C1-670859F1383EQ53250601-703D5760-1CD4-47E3-97A2-CFAD3B726AA3Q53401460-56B6C86D-DAF1-429E-9FBE-AD43BB2C2D08Q55362797-58BF2C9D-9F8D-437A-99C1-0DF758148BB0Q58055764-2A85BFA8-ABE0-4BCF-8D8D-79123879DA5E
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Advanced glycation end products and insulin resistance.
@ast
Advanced glycation end products and insulin resistance.
@en
Advanced glycation end products and insulin resistance.
@nl
type
label
Advanced glycation end products and insulin resistance.
@ast
Advanced glycation end products and insulin resistance.
@en
Advanced glycation end products and insulin resistance.
@nl
prefLabel
Advanced glycation end products and insulin resistance.
@ast
Advanced glycation end products and insulin resistance.
@en
Advanced glycation end products and insulin resistance.
@nl
P1476
Advanced glycation end products and insulin resistance.
@en
P2093
Hiroyuki Unoki
Sho-ichi Yamagishi
P304
P356
10.2174/138161208784139747
P577
2008-01-01T00:00:00Z